Recent Company News

• 01:04 AM ET Jun 09, 2026
  

  Biophytis announces the official registration of its joint venture in Hong Kong, Biophytis Biopharmaceutical Group Limited (€0.02, 0.00)

• 04:52 AM ET Jan 28, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 01:12 AM ET Jun 02, 2026
  

  Biophytis submits the registration filing for its joint venture in Hong Kong with its Asian partners (€0.02, 0.00)

• 05:10 PM ET Apr 29, 2026
  

  Biophytis postpones publication of financial statements (€0.02, 0.00)

• 02:31 AM ET Mar 12, 2026
  

  Biophytis-Lynxkite alliance expands to turbocharge AI-driven drug discovery for next generation longevity therapeutics (€0.03, 0.00)

• 01:47 AM ET Jan 28, 2026
  

  Biophytis enters strategic agreement in Asia and secures $20M for launch of Phase 3 trial of BIO101 in sarcopenia (€0.06, 0.00)

• 06:20 PM ET Oct 30, 2025
  

  Biophytis reports H1 net income (€3.5M) vs year-ago (€5.8M) (€0.11, 0.00)